Product Details
- DuoTrav Eye Drops 2.5 mL is a prescription ophthalmic solution used to lower elevated intraocular pressure in adults with open-angle glaucoma or ocular hypertension.
- The formulation combines travoprost, a prostaglandin analogue, and timolol, a beta-blocker, to provide enhanced pressure reduction compared with either ingredient used alone.
- It is intended for adults, including the elderly, who have not responded adequately to other single-agent beta-blocker or prostaglandin eye drops.
- The clear, sterile, isotonic solution is supplied in a convenient 2.5 mL dropper bottle for once-daily use in the affected eye(s).
- DuoTrav Eye Drops help reduce the risk of optic nerve damage and potential vision loss associated with uncontrolled high eye pressure.
Key Features:
- Dual-Action Formula: Combines travoprost 40 micrograms/mL and timolol 5 mg/mL (0.004% travoprost and 0.5% timolol) to both increase aqueous fluid outflow and decrease fluid production in the eye.
- Indicated for Glaucoma and Ocular Hypertension: Specifically indicated to lower intraocular pressure in adults with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
- Once-Daily Dosing: Recommended dose is one drop in the conjunctival sac of the affected eye(s) once daily, either in the morning or evening, at the same time each day.
- Clear Ophthalmic Solution: Supplied as a clear, colorless to slightly yellow sterile eye-drop solution in a 2.5 mL bottle designed for precise drop delivery.
- Prescription-Only Medicine: Classified as a prescription-only antiglaucoma preparation, ensuring use under medical supervision.
- Detailed Application Instructions: Usage directions include hand washing, avoiding contact of the dropper tip with any surface, proper eyelid positioning, and nasolacrimal occlusion or gentle eye closure for about 2 minutes after instillation.
- Contact Lens Guidance: Contact lenses should be removed before instillation and may be reinserted 15 minutes after using the drops to avoid interaction with the preservative.
- Storage Conditions: Typically stored below 25–30 °C, protected from light, and discarded 4 weeks after opening (or up to 120 days in some markets, following local instructions).
- Safety Profile: Common side effects include ocular hyperemia (eye redness), eye irritation, dry eyes, blurred vision, and itching, with detailed precautions for patients with asthma, severe COPD, certain heart conditions, diabetes, or a history of severe allergic reactions.
- International Availability: Marketed by Novartis in multiple regions (EU, Australia, Canada, UK, Korea) under the DuoTrav/DUOTRAV brand, reflecting broad clinical use and regulatory approval.
